TOP TIERMARKET NEWSWIRE
News & sentiment

CELLDEX THERAPEUTICS (CLDX) — News & AI sentiment

CELLDEX THERAPEUTICS (CLDX) news roundup. 1 story in the past week, 10 over 30 days. Average 30-day sentiment is 48.4/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 73/100
30d stories
10
avg sentiment 48.4/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on CLDX

4d ago
Jul 22
Canaccord cuts Celldex stock price target after trial miss
Investing.com Analyst Ratings34 · bearishanalyst
Jul 22
Jul 21
Jul 21
After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
Investing.com Markets50 · neutralgeneral
Jul 21
Jul 21
Guggenheim raises Celldex stock price target on trial outlook
Investing.com Analyst Ratings61 · neutralanalyst
Jul 20
Jul 15
Jun 30
Jun 26
Jun 24
Jun 14
Jun 14
Jun 14
Jun 10
Open CLDX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →